Metabolic Syndrome is a set of risk factors, essentially cardiovascular, which are based on Abdominal Obesity. Individuals with this syndrome are at risk of developing cardiovascular disease (heart attack and stroke) and diabetes, even when the risk factors are only slightly elevated. Levezza Stop Fat has anti-inflammatory action direct to the adipose tissue, in addition, it decreases the levels of cholesterol and triglycerides and inhibits platelet aggregation. It reduces the absorption of cholesterol at the intestinal level, helps to control the desire to eat sweets and supports the regulation of blood glucose values. In addition, it reduces the formation of glucose by the liver, since it inhibits the release of glucose into the bloodstream, this action translates into an increased use of fats as an energy source.

Therapeutic indications:
Draining action and detoxifying action
Overweight
Visceral Fat
Limits the absorption of carbohydrates
Fluid retention
Metabolic syndrome